Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Watkins

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Molecular Pharmacology|April 1, 1986
Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the ratS A Wrighton, C Campanile, P E Thomas, et al.
The Journal of Clinical Investigation|May 15, 1997
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expressionK S Lown, D G Bailey, R J Fontana, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2014
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILIJ L Woodhead, K Yang, K L R Brouwer, et al.
Biochemistry|November 4, 1986
Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylaseS A Wrighton, P E Thomas, D T Molowa, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Clinical Pharmacology and Therapeutics|May 1, 1997
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath testC L Cheng, D E Smith, P L Carver, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteersA H Harrill, J Roach, I Fier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Molecular Pharmacology|April 1, 1986
Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the ratS A Wrighton, C Campanile, P E Thomas, et al.
The Journal of Clinical Investigation|May 15, 1997
Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expressionK S Lown, D G Bailey, R J Fontana, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2014
Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid-Mediated DILIJ L Woodhead, K Yang, K L R Brouwer, et al.
Biochemistry|November 4, 1986
Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylaseS A Wrighton, P E Thomas, D T Molowa, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Clinical Pharmacology and Therapeutics|May 1, 1997
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath testC L Cheng, D E Smith, P L Carver, et al.
Clinical Pharmacology and Therapeutics|May 6, 2011
Case definition and phenotype standardization in drug-induced liver injuryG P Aithal, P B Watkins, R J Andrade, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteersA H Harrill, J Roach, I Fier, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarinsP Schmiedlin-Ren, D J Edwards, M E Fitzsimmons, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporineK S Lown, R R Mayo, A B Leichtman, et al.
Pageof 10